Capital Rx Secures $50 Million to Redefine Prescription Pricing
Capital Rx Secures $50 Million to Redefine Prescription Pricing What You Should Know: – Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., announced today that it has raised $50 million in Series B financing. – Following the recent launch of JUDITM, the industry’s first Enterprise Pharmacy Platform, Capital Rx will continue to expand the platform’s capabilities, including leveraging AI to improve clinical care. Capital Rx, a New York City-based pharmacy benefit manager in the U.S., announced it has raised $50 million in Series B funding led by Transformational Capit...
Source: hitconsultant.net